Showing results (1-10 of 256) with videos related to
Sort By:
Pageof 26
Expert Opinion on Biological Therapy|May 10, 2024
Switching CGRP(r) MoAbs in migraine: what evidence?William David Wells-Gatnik, Paolo MartellettiExpert Review of Neurotherapeutics|September 12, 2024
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraineWilliam David Wells-Gatnik, Lanfranco Pellesi, Paolo MartellettiInternational Journal of Environmental Research and Public Health|November 26, 2022
Reaching the Nadir of Medication Overuse in Chronic MigraineDilara Onan, William David Wells-Gatnik, Paolo MartellettiDrugs & Aging|February 24, 2023
New Migraine Drugs for Older AdultsDilara Onan, William David Wells-Gatnik, Enrico Bentivegna, et al.Expert Opinion on Investigational Drugs|September 6, 2023
Emerging experimental drugs in clinical trials for migraine: observations and key talking pointsWilliam David Wells-Gatnik, Tiffany Yazmin Wences Chirino, Fatma Nur Onan, et al.Expert Opinion on Pharmacotherapy|June 2, 2015
Cluster headache management and beyondPaolo MartellettiBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 11, 2017
The Application of CGRP(r) Monoclonal Antibodies in Migraine Spectrum: Needs and PrioritiesPaolo MartellettiCurrent Pain and Headache Reports|July 4, 2002
Inflammatory mechanisms in cervicogenic headache: an integrative viewPaolo MartellettiInternational Journal of Environmental Research and Public Health|March 11, 2023
COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for HeadachePaolo MartellettiInternational Journal of Environmental Research and Public Health|March 29, 2023
One Health for Headaches: A Clinical Scientist Residence ProjectPaolo MartellettiPageof 26